Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
RiboX Therapeutics Announces FDA Clearance for IND Application of RXRG001, the First Circular RNA Therapy for the Treatment of Radiation-Induced Xerostomia and Hyposalivation
2024-10-26 01:24
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
2024-10-25 20:30
HiConf Seoul 2024 successfully wraps up, sparks up discussions for future of food tech and international partnerships
2024-10-25 10:39
Innovation at the Forefront: Angel Yeast Shines at FHA 2024
2024-10-24 20:30
Global Biopharma Thought Leaders Gather in London: Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights
2024-10-24 17:53
J INTS BIO Presents Interim Findings from Phase 1/2 Clinical Trial of 4th-Generation EGFR-TKI 'JIN-A02' in NSCLC: A Potential Breakthrough in Overcoming Acquired Resistance to Targeted Therapy
2024-10-24 12:42
J INTS BIO Presents Interim Results from the Preclinical Study of 'JIN-001' in Refractory Ovarian Cancer: A Promising Solution for Overcoming Drug Resistance
2024-10-24 10:45
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
2024-10-24 10:00
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation
2024-10-24 08:08
Lunit AI Predicts Breast Cancer Risk Up to 6 Years in Advance
2024-10-23 21:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
2024-10-23 20:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
2024-10-23 15:11
Samsung Biologics reports third quarter 2024 financial results
2024-10-23 14:55
Australia's Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit
2024-10-23 09:29
Bloomage 'YunZhong (In Cloud) Public Welfare' Campaign: A 14-Year Journey of Cultural Preservation and Sustainability
2024-10-22 21:00
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
2024-10-22 18:57
Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED)
2024-10-22 18:00
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
2024-10-22 13:47
【C.S】Cordyceps Sunshine Biotech Uplists to OTCQB, Aims for a Potential Nasdaq Uplisting
2024-10-22 06:00
Origin Agritech Establishes Biotechnology Service Consortium to Accelerate Licensing and Commercialization of GMO and Gene Editing Technologies
2024-10-21 19:30
1
5
6
7
8
9
451